Literature DB >> 11192620

High frequency repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal cortex in schizophrenic patients.

J D Rollnik1, T J Huber, H Mogk, S Siggelkow, S Kropp, R Dengler, H M Emrich, U Schneider.   

Abstract

Repetitive transcranial magnetic stimulation (rTMS) has been tried therapeutically in major depression. In order to investigate the therapeutic efficacy of rTMS in psychotic patients, 12 participants (four women, eight men) with schizophrenia according to DSM-IV criteria, aged 25 to 63 years (mean (+/-s.d) 40.4+/-11.0), were enrolled in the study. Following a double-blind crossover design, patients were treated at random with 2 weeks of daily left prefrontal rTMS (20 2s 20 Hz stimulations at 80% motor threshold over 20 min, dorsolateral preforntal cortex) and 2 weeks of sham stimulation. The Brief Psychiatric Rating Scale decreased under active rTMS (p <0.05), whereas depressive symptoms (BDI) and anxiety (STAI) did not change significantly. Prefrontal rTMS might be effective in the non-pharmacological treatment of psychotic patients.

Entities:  

Mesh:

Year:  2000        PMID: 11192620     DOI: 10.1097/00001756-200012180-00022

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  22 in total

1.  Neuromodulation and Transcranial Mag Netic Stimulation (TMS): A 21st Century Paradigm for Therapeutics in Psychiatry.

Authors:  John P O'Reardon; Andrew D Peshek; Rocio Romero; Pilar Cristancho
Journal:  Psychiatry (Edgmont)       Date:  2006-01

2.  Therapeutic effects of individualized alpha frequency transcranial magnetic stimulation (alphaTMS) on the negative symptoms of schizophrenia.

Authors:  Yi Jin; Steven G Potkin; Aaron S Kemp; Steven T Huerta; Gustavo Alva; Trung Minh Thai; Danilo Carreon; William E Bunney
Journal:  Schizophr Bull       Date:  2005-10-27       Impact factor: 9.306

Review 3.  Does Therapeutic Repetitive Transcranial Magnetic Stimulation Cause Cognitive Enhancing Effects in Patients with Neuropsychiatric Conditions? A Systematic Review and Meta-Analysis of Randomised Controlled Trials.

Authors:  Donel M Martin; Shawn M McClintock; Jane Forster; Colleen K Loo
Journal:  Neuropsychol Rev       Date:  2016-09-08       Impact factor: 7.444

Review 4.  Can noninvasive brain stimulation enhance cognition in neuropsychiatric disorders?

Authors:  Asli Demirtas-Tatlidede; Andrew M Vahabzadeh-Hagh; Alvaro Pascual-Leone
Journal:  Neuropharmacology       Date:  2012-06-28       Impact factor: 5.250

Review 5.  Transcranial Magnetic Stimulation : A New Therapeutic Tool in Psychiatry.

Authors:  A A Pawar; D Saldanha; S Chaudhury; Vssr Ryali; K Srivastava
Journal:  Med J Armed Forces India       Date:  2011-07-21

6.  Revisiting the therapeutic effect of rTMS on negative symptoms in schizophrenia: a meta-analysis.

Authors:  Chuan Shi; Xin Yu; Eric F C Cheung; David H K Shum; Raymond C K Chan
Journal:  Psychiatry Res       Date:  2013-12-21       Impact factor: 3.222

Review 7.  Efficacy of Transcranial Magnetic Stimulation (TMS) in the Treatment of Schizophrenia: A Review of the Literature to Date.

Authors:  Jonathan C Cole; Carolyn Green Bernacki; Amanda Helmer; Narsimha Pinninti; John P O'reardon
Journal:  Innov Clin Neurosci       Date:  2015 Jul-Aug

8.  Longlasting antalgic effects of daily sessions of repetitive transcranial magnetic stimulation in central and peripheral neuropathic pain.

Authors:  E M Khedr; H Kotb; N F Kamel; M A Ahmed; R Sadek; J C Rothwell
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-06       Impact factor: 10.154

Review 9.  Repetitive Noninvasive Brain Stimulation to Modulate Cognitive Functions in Schizophrenia: A Systematic Review of Primary and Secondary Outcomes.

Authors:  Alkomiet Hasan; Wolfgang Strube; Ulrich Palm; Thomas Wobrock
Journal:  Schizophr Bull       Date:  2016-07       Impact factor: 9.306

10.  Meta-analysis of the effects of repetitive transcranial magnetic stimulation (rTMS) on negative and positive symptoms in schizophrenia.

Authors:  Catarina Freitas; Felipe Fregni; Alvaro Pascual-Leone
Journal:  Schizophr Res       Date:  2009-01-11       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.